11-45910168-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004813.4(PEX16):​c.*86G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,459,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

PEX16
NM_004813.4 3_prime_UTR

Scores

1
1
14

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: -0.711

Publications

0 publications found
Variant links:
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 8A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • peroxisome biogenesis disorder 8B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07880655).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX16NM_004813.4 linkc.*86G>C 3_prime_UTR_variant Exon 11 of 11 ENST00000378750.10 NP_004804.2 Q9Y5Y5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX16ENST00000241041.7 linkc.962G>C p.Arg321Pro missense_variant Exon 11 of 11 1 ENSP00000241041.3 Q9Y5Y5-2
PEX16ENST00000378750.10 linkc.*86G>C 3_prime_UTR_variant Exon 11 of 11 1 NM_004813.4 ENSP00000368024.5 Q9Y5Y5-1
PEX16ENST00000532681.5 linkc.*86G>C downstream_gene_variant 3 ENSP00000434654.1 E9PP98
PEX16ENST00000523721.2 linkn.*2G>C downstream_gene_variant 5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.0000144
AC:
21
AN:
1459786
Hom.:
0
Cov.:
32
AF XY:
0.00000964
AC XY:
7
AN XY:
726178
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33424
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86178
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53142
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4368
European-Non Finnish (NFE)
AF:
0.0000162
AC:
18
AN:
1111902
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PEX16-related disorder Uncertain:1
Jul 10, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PEX16 c.962G>C variant is predicted to result in the amino acid substitution p.Arg321Pro. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.89
DANN
Benign
0.67
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.32
T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.079
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.71
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.33
N
REVEL
Benign
0.015
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.040
D
Polyphen
0.0
B
Vest4
0.072
MutPred
0.60
Gain of glycosylation at R321 (P = 0.0172);
MVP
0.10
MPC
0.52
ClinPred
0.22
T
GERP RS
-3.6
gMVP
0.54
Mutation Taster
=96/4
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146486656; hg19: chr11-45931719; API